FREEDOM-1 clinical trial - Business-News-Today.com

Talaris initiates FREEDOM-1 clinical trial for FCR001 in LDKT recipients

pharmanewsdaily - October 24, 2019 0

Talaris Therapeutics has initiated the phase 3 FREEDOM-1 clinical trial to evaluate its investigational, allogeneic cell therapy FCR001 in living donor kidney transplant (LDKT) recipients. ... Read More

Talaris initiates FREEDOM-1 clinical trial for FCR001 in LDKT recipients

Sonoco to sell thermoformed and flexibles packaging business to Toppan for $1.8bn

First Commonwealth to expand Cincinnati footprint with CenterGroup acquisition

Strategic Storage Growth Trust III expands Canadian portfolio with Alberta acquisition

Pacific Seafood acquires Trident’s Kodiak processing operations

Woodside to streamline portfolio with Chevron asset swap to unlock LNG value

Cognition Therapeutics reports promising Phase 2 results for CT1812 in dementia with Lewy bodies

Polyrizon prepares for allergy blocker trial with strategic manufacturing partnership

American Battery Technology gets DOE grant for second lithium-ion battery recycling facility

Could Ukraine-war drone tech solve the US UFO mystery?

First severe case of H5N1 Bird Flu in humans sparks U.S. health concerns

Tragedy strikes off Mumbai coast: 13 dead as navy boat crashes into ferry

Cubico finalises financing for 500MW Wambo Wind Farm in Queensland

Equinor strengthens North Sea portfolio with Ringand discovery

Ford and SK On’s JV BlueOval SK receives record-breaking loan for U.S. battery plants

HomeTown expands presence with grand opening at Seasons Mall, Pune

Dynamatic Technologies awards Aequs contract for Airbus A220 door components

Aurionpro subsidiary Arya.ai unveils AryaXAI to ensure AI regulatory compliance

Shriram Finance secures landmark multi-currency loan of $1.28bn

KFin Technologies teams up with BlackRock Aladdin: A step towards digital efficiency

Blue Cloud Softech Solutions marks milestone with US AIoT project